表紙
市場調查報告書
商品編碼
965039

藥物分析測試市場的增長,趨勢和預測(2020-2025)

Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

預計全球藥物分析試驗市場在預測期內將以6.5%的複合年增長率增長。市場增長的主要動力是生物學分析和臨床試驗的增加。在美國和韓國,每年約有40種藥物被召回。這使得必須對產品進行測試以確保其安全性。藥品質量差不僅嚴重影響患者的健康,而且嚴重影響資金系統。因此,分析試驗對確保藥物的安全性和有效性起著重要作用。

本報告調查了藥品分析測試市場,分析了市場概況,市場增長因素和障礙,按類型和地區,競爭情況,主要公司的概況和市場對市場規模的變化和預測。它提供了諸如機會之類的全面信息。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 臨床試驗數量增加
    • 生物製品和生物仿製藥的分析測試
  • 市場限制
    • 數據安全
  • 波特的五力分析

第5章市場細分

  • 按測試類型
    • 生物分析測試服務
    • 方法開發和驗證
    • 穩定性測試
    • API
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Laboratory Testing Inc.
    • Eurofins Scientific
    • SGS SA
    • Toxikon Inc.
    • Pace Analytical Services
    • Intertek Phamaceutical Services
    • Boston Analytical
    • West Pharmaceutical Services Inc.
    • Steris

第7章 市場機會與動向

目錄
Product Code: 70691

The pharmaceutical analytical testing market is expected to register a CAGR of 6.5% over the forecast period. The key contributors in the market growth are focus on analytical testing of biologics and increasing number of clinical trials. According to the International Journal of Environmental Research and Public Health's published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and ensure safety. Medicines are intended for better outcome in humans and animals. However, poor quality of medicines would not only affect adevrsely on the health of the patients but also on the fund systems. Therefore, to ensure safety and efficacy of the drugs analytical testing holds an important role.

Key Market Trends

Stability Testing Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Statbility testing is done to evaluate the capability of the drug to retain it's properties throughout it's shelf-life. The stability testing is done on the basis of five parameters : Chemical, physical, microbiological, therapeutic and toxicity. The degredation with respect to any of these parameters can lead to health hazards. According to the study published by Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decaded. Furthermore, according to the World Health Organization, in 2019, the number of registered trials were around 92% in South East Asia and around 66% in the Eastern Mediterranean region. Hence, these factors are expected to impact positively on the market growth in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Pharmaceutical Analytical Testing market owing to increasing number of R&D activities and investments on it. According to the clinical trials.gov, in 2019, around 293,321 studies were registered during the start of the year and around 32,523 at the end of year. Furthermore, in 2019, approximately 48 novel drugs were approved as per the data of the FDA's Center for Drug Evaluation and Research (CDER). According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies were around 79.6 billion USD in the United States. Thus, the increasing number of clinical trials and number of approved drugs is expected to boost up the demand of pharmaceutical analytical testing market growth in the North America Region.

Competitive Landscape

The Pharmaceutical Analytical Testing market consists of several interational as well as local companies. Some of the well-known companies in this market include Laboratory Testing Inc., Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc. and Steris

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Clinical Trials
    • 4.2.2 Focus on Analytical Testing of Biologics & Biosimilars
    • 4.2.3 Increased Trend of Outsourcing Laboratory Testing Services
  • 4.3 Market Restraints
    • 4.3.1 Complex Regulatory Framework for Maintaining Laboratories
    • 4.3.2 Challenges in the Development of Proper Analytical Techniques
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Service Type
    • 5.1.1 Bioanalytical Testing
    • 5.1.2 Method Development & Validation
    • 5.1.3 Stability Testing
    • 5.1.4 Drug Substances Testing
    • 5.1.5 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Laboratory Testing Inc.
    • 6.1.2 Eurofins Scientific
    • 6.1.3 SGS SA
    • 6.1.4 Toxikon Inc.
    • 6.1.5 Pace Analytical Services
    • 6.1.6 Intertek Phamaceutical Services
    • 6.1.7 Boston Analytical
    • 6.1.8 West Pharmaceutical Services Inc.
    • 6.1.9 Steris

7 MARKET OPPORTUNITIES AND FUTURE TRENDS